Antibodies inhibiting c-Met dimerization, and uses thereof
US8889832B2 · kind B2 · utility
4Cited by
1References
55Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 9, 2012 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | Nov 28, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present inventions relates to a process for the selection of anti c-Met antibodies capable to inhibit both ligand-dependent and ligand-independent activation of c-Met. More particularly, said process is based on the inhibition of the c-Met dimerization. In another aspect, the present invention concerns such antibodies and compositions comprising such antibodies for the preparation of a medicament to treat cancer. Diagnosis process and kits are also part of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.